Table 1 Description and characteristics of the eligible studies
Study | Year | Country | Study design | Total study population | Type of surgery | Time of outcome evaluation (month) | Quality assessmenta | Comparator |
|---|---|---|---|---|---|---|---|---|
Thomas | 2004 | UK | Retrospective cohort | 84 | TURP | 135.6 (mean) | 7 | Without surgery |
Masumori | 2010 | Japan | Retrospective self-controlled | 12 | TURP | 3, 36, 84 | 7 | Before surgery |
Choi | 2011 | Korea | Retrospective self-controlled | 371 | PVP | 1, 12 | 8 | Before surgery |
Yu | 2015 | China | Retrospective self-controlled | 78 | PVP | 12 | 8 | Before surgery |
Sokhal | 2017 | India | Retrospective self-controlled | 174 | TURP | 3 | 8 | Before surgery |
Lee | 2019 | China | Retrospective self-controlled | 60 | TURP/TUIP | 3 | 8 | Before surgery |
Thomas | 2019 | USA | Retrospective self-controlled | 106 | PVP | 1, 3, 6, 12 | 8 | Before surgery |
Rubilotta | 2020 | Italy | Prospective self-controlled | 51 | TURP | More than 24 (mean) | 9 | Before surgery |
Wu | 2020 | China | Retrospective self-controlled | 48 | TURP/TUIP | 24.9 (mean) | 8 | Before surgery |
Lebani | 2023 | Brazil | Prospective self-controlled | 158 | TURP | 1,6,12 | 9 | Before surgery |